09:49 AM EDT, 08/21/2024 (MT Newswires) -- Scilex Holding ( SCLX ) said Wednesday that it is set to receive a new patent from the US Patent and Trademark Office later this year covering its claims related to acute pain treatment.

The company said the US Patent and Trademark Office "has allowed numerous claims" from its patent application, but did not disclose further details.

Scilex ( SCLX ) said the new patent is expected to strengthen its intellectual property position and coverage for Elyxyb, its acute migraine treatment.

Price: 1.29, Change: +0.03, Percent Change: +2.30